Since 49–61% of chondrosarcomas harbour an IDH1/2 mutation, additional mutation testing can be helpful to distinguish between these differential diagnoses in which the finding of an IDH1/2 mutation is diagnostic for chondrosarcoma and excludes chondroblastic osteosarcoma [11–13]. The gene discussed is IDH1; the disease is chondroblastic osteosarcoma.